May 6, 2026 07:06AM
May 6, 2026 07:00AM
Apr 29, 2026 07:00AM
Mar 5, 2026 06:52AM
Mar 4, 2026 02:56PM
Mar 4, 2026 07:03AM
Mar 4, 2026 07:00AM EyePoint Reports Fourth Quarter and Full-Year 2025 Financial Results and Highlights Recent Corporate Developments
Feb 25, 2026 07:00AM
Nov 5, 2025 07:05AM
Nov 5, 2025 07:00AM
Oct 29, 2025 07:00AM
Aug 6, 2025 07:03AM
Aug 6, 2025 07:00AM
Jul 30, 2025 07:00AM EyePoint to Report Second Quarter 2025 Financial Results on August 6, 2025
May 7, 2025 07:06AM
May 7, 2025 07:00AM
Apr 30, 2025 07:00AM
Mar 6, 2025 07:24AM
Mar 5, 2025 07:04AM
Mar 5, 2025 07:00AM
Feb 26, 2025 07:00AM EyePoint to Report Fourth Quarter and Full-Year 2024 Financial Results on March 5, 2025
Nov 11, 2024 07:24AM
Nov 7, 2024 05:14PM
Nov 7, 2024 07:00AM
Aug 7, 2024 07:07AM
Aug 7, 2024 07:00AM
May 13, 2024 07:19AM
May 8, 2024 07:00AM EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
Mar 7, 2024 07:02AM
Mar 7, 2024 07:00AM
Feb 29, 2024 07:00AM
Dec 4, 2023 05:32PM
Nov 1, 2023 07:22AM
Oct 25, 2023 07:00AM
Aug 2, 2023 07:06AM EyePoint Pharmaceuticals (EYPT) Tops Q2 EPS by 8c
Aug 2, 2023 07:00AM
Jul 26, 2023 07:00AM
May 3, 2023 07:29AM
Apr 26, 2023 07:00AM
Mar 2, 2023 07:37AM
Mar 2, 2023 07:00AM
Feb 23, 2023 07:00AM EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on March 2, 2023
Nov 2, 2022 07:14AM
Nov 2, 2022 07:00AM
Oct 26, 2022 07:00AM
Sep 21, 2022 09:00PM
Sep 16, 2022 09:00PM
Sep 11, 2022 09:00PM
Sep 6, 2022 09:15PM Bragar Eagel & Squire, P.C. Is Investigating Singularity, Phathom, EyePoint, and Olo and Encourages Investors to Contact the Firm
Aug 3, 2022 07:18AM

1,199,633 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All